Key result
Intradermal immunization with living poliomyelitis virus conferred greater protection against intracerebral inoculation in monkeys than subcutaneous injection.
Answers are grounded in this paper and cite their sources.
Intradermal route may enhance protection in primate models; leaves open optimal immunization strategies for human poliomyelitis.
The introduction of considerable amounts of living, active poliomyelitis virus into the skin and subcutaneous tissue of monkeys protects the animals against intracerebral inoculations of similar virus material. 2. The degree of protection conferred by intradermal is greater than by subcutaneous injection. 3. During intradermal and subcutaneous inoculations, no local or general pathological signs were observed. 4. The degree of protection produced by the immunization methods used is not absolute, since a percentage of the inoculated monkeys respond to intracerebral injections of highly potent virus. 5. The sera of the animals inoculated intradermally or subcutaneously neutralized poliomyelitis virus in vitro, irrespective of the result of intracerebral inoculation, in all except one instance. 6. The power of the serum of treated monkeys to neutralize virus in vitro is a more delicate test of immunity than is the intracerebral inoculation.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (1929) studied Poliomyelitis. Intradermal immunization with living, active poliomyelitis virus vs. Subcutaneous immunization was evaluated on Protection against intracerebral inoculations of poliomyelitis virus. Intradermal immunization with living poliomyelitis virus conferred greater protection against intracerebral inoculation in monkeys than subcutaneous injection.
Synapse has enriched 10 related papers. Consider them for comparative context: